Bide Pharmatech Co. Ltd. A Tangible Net Worth Ratio
Bide Pharmatech Co. Ltd. A tangible net worth ratio. Bide Pharmatech Co. Ltd. A (688073) has a Tangible Net Worth Ratio of 99.8% as of March 2026. This metric is calculated by deducting intangible assets (CN¥4.76 Million) from net assets (CN¥2.10 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Bide Pharmatech Co. Ltd. A equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Bide Pharmatech Co. Ltd. A (2020–2025)
Tangible net worth ratio of Bide Pharmatech Co. Ltd. A from 2020 to 2025. This chart shows how Bide Pharmatech Co. Ltd. A's Tangible Net Worth Ratio has changed across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 99.8%, reflecting net assets of CN¥2.10 Billion with intangible assets of CN¥4.76 Million CNY.
Bide Pharmatech Co. Ltd. A Tangible Net Worth Ratio by Year (2020–2025)
Bide Pharmatech Co. Ltd. A tangible net worth ratio by year from 2020 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Bide Pharmatech Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Bide Pharmatech Co. Ltd. A stock valuation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.8% | CN¥2.05 Billion | CN¥4.93 Million | CN¥2.52 Billion | ▼ 0.0 pp |
| 2024 | 99.8% | CN¥2.03 Billion | CN¥3.95 Million | CN¥2.42 Billion | ▼ -0.2 pp |
| 2023 | 100.0% | CN¥2.09 Billion | CN¥600.72K | CN¥2.42 Billion | ▼ 0.0 pp |
| 2022 | 100.0% | CN¥2.08 Billion | CN¥211.75K | CN¥2.36 Billion | ▲ +0.1 pp |
| 2021 | 99.9% | CN¥628.86 Million | CN¥442.75K | CN¥906.13 Million | ▲ +0.1 pp |
| 2020 | 99.8% | CN¥364.26 Million | CN¥675.83K | CN¥531.90 Million | — |